Contrasting Longevity Health (XAGE) and Its Competitors

Institutional & Insider Ownership

24.2% of Longevity Health shares are held by institutional investors. Comparatively, 19.3% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by institutional investors. 29.0% of Longevity Health shares are held by insiders. Comparatively, 17.9% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Longevity Health and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Longevity Health	$1.05 million	-$10.37 million	-0.11
Longevity Health Competitors	$62.62 million	-$29.77 million	1.60

Longevity Health’s peers have higher revenue, but lower earnings than Longevity Health. Longevity Health is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Longevity Health has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, Longevity Health’s peers have a beta of 1.80, meaning that their average stock price is 80% more volatile than the S&P 500.

Profitability

This table compares Longevity Health and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Longevity Health	-682.67%	N/A	-261.90%
Longevity Health Competitors	-500.48%	-110.93%	-48.62%

Summary

Longevity Health peers beat Longevity Health on 5 of the 9 factors compared.

About Longevity Health

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.